Latest news
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition - TradingViewTradingView · Wed, 05 Aug 2026 20:04:07 GMTEDGAR Filing Documents for 0001193125-26-333861 - SEC.govSEC.gov · Wed, 05 Aug 2026 15:36:01 GMTLOGC Looks 884.6% Overvalued on GF Value™ - GuruFocusGuruFocus · Wed, 05 Aug 2026 14:23:47 GMTLOGC: Acquisition of gChem for $850M boosts free cash flow and strengthens niche business portfolio - TradingViewTradingView · Wed, 05 Aug 2026 13:26:23 GMTLOGC: Acquisition of gChem for $850M boosts specialty chemicals presence and free cash flow - TradingViewTradingView · Wed, 05 Aug 2026 11:49:25 GMTContextLogic (NASDAQ: LOGC) buys gChem in $850 million cash acquisition - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:25 GMT64-year-old gChem Expected to Become ContextLogic's Second Business - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMTContextLogic Holdings Inc. (LOGC.MX) insider ownership and holdings - Yahoo Finance AustraliaYahoo Finance Australia · Wed, 05 Aug 2026 05:32:43 GMT